BACKGROUND: An active cognitive lifestyle is linked to diminished dementia risk, but the underlying mechanisms are poorly understood. Potential mechanisms include disease modification, neuroprotection, and compensation. Prospective, population-based brain series provide the rare opportunity to test the plausibility of these mechanisms in humans. METHODS: Participants came from the United Kingdom Medical Research Council Cognitive Function and Ageing Study, comprising 13,004 individuals aged over 65 years and followed for 14 years. In study 1, a Cognitive Lifestyle Score (CLS) was computed on all Cognitive Function and Ageing Study subjects to define low, middle, and high groups. By August 2004, 329 individuals with CLS data had come to autopsy and underwent Consortium to Establish a Registry of Alzheimer's Disease assessment. Study 2 involved more detailed quantitative histology in the hippocampus and Brodmann area 9 in 72 clinically matched individuals with high and low CLS. RESULTS: CLS groups did not differ on several Alzheimer disease neuropathologic measures; however, high CLS men had less cerebrovascular disease after accounting for vascular risk factors, and women had greater brain weight. No group differences were evident in hippocampal neuronal density. In Brodmann area 9, cognitively active individuals had significantly greater neuronal density, as well as correlated increases in cortical thickness. CONCLUSIONS: An active cognitive lifestyle was associated with protection from cerebrovascular disease in men, but there was no evidence for Alzheimer disease modification or hippocampal neuroprotection. Men and women both exhibited neurotrophic changes in the prefrontal lobe linked to cognitive lifestyle, consistent with a compensatory process. Lifespan complex cognitive activity may therefore protect against dementia through multiple biological pathways.
BACKGROUND: An active cognitive lifestyle is linked to diminished dementia risk, but the underlying mechanisms are poorly understood. Potential mechanisms include disease modification, neuroprotection, and compensation. Prospective, population-based brain series provide the rare opportunity to test the plausibility of these mechanisms in humans. METHODS:Participants came from the United Kingdom Medical Research Council Cognitive Function and Ageing Study, comprising 13,004 individuals aged over 65 years and followed for 14 years. In study 1, a Cognitive Lifestyle Score (CLS) was computed on all Cognitive Function and Ageing Study subjects to define low, middle, and high groups. By August 2004, 329 individuals with CLS data had come to autopsy and underwent Consortium to Establish a Registry of Alzheimer's Disease assessment. Study 2 involved more detailed quantitative histology in the hippocampus and Brodmann area 9 in 72 clinically matched individuals with high and low CLS. RESULTS:CLS groups did not differ on several Alzheimer disease neuropathologic measures; however, high CLSmen had less cerebrovascular disease after accounting for vascular risk factors, and women had greater brain weight. No group differences were evident in hippocampal neuronal density. In Brodmann area 9, cognitively active individuals had significantly greater neuronal density, as well as correlated increases in cortical thickness. CONCLUSIONS: An active cognitive lifestyle was associated with protection from cerebrovascular disease in men, but there was no evidence for Alzheimer disease modification or hippocampal neuroprotection. Men and women both exhibited neurotrophic changes in the prefrontal lobe linked to cognitive lifestyle, consistent with a compensatory process. Lifespan complex cognitive activity may therefore protect against dementia through multiple biological pathways.
Authors: Moriel Zelikowsky; Stephanie Bissiere; Timothy A Hast; Rebecca Z Bennett; Andrea Abdipranoto; Bryce Vissel; Michael S Fanselow Journal: Proc Natl Acad Sci U S A Date: 2013-05-15 Impact factor: 11.205
Authors: M Kathryn Jedrziewski; Douglas C Ewbank; Haidong Wang; John Q Trojanowski Journal: Am J Alzheimers Dis Other Demen Date: 2014-01-08 Impact factor: 2.035
Authors: Fred Stephen Sarfo; John Akassi; Sheila Adamu; Vida Obese; Bruce Ovbiagele Journal: J Stroke Cerebrovasc Dis Date: 2017-06-23 Impact factor: 2.136
Authors: Meredith A Shafto; Richard N Henson; Fiona E Matthews; Jason R Taylor; Tina Emery; Sharon Erzinclioglu; Claire Hanley; James B Rowe; Rhodri Cusack; Andrew J Calder; William D Marslen-Wilson; John Duncan; Tim Dalgleish; Carol Brayne; Lorraine K Tyler Journal: J Aging Health Date: 2019-10-08
Authors: Stefanie Schreiber; Jacob Vogel; Henry D Schwimmer; Shawn M Marks; Frank Schreiber; William Jagust Journal: Neurobiol Aging Date: 2016-01-30 Impact factor: 4.673